Anglo-French Drugs & Industries reports standalone net profit of Rs 3.10 crore in the March 2024 quarter
Sales decline 31.32% to Rs 20.55 crore
Net profit of Anglo-French Drugs & Industries reported to Rs 3.10 crore in the quarter ended March 2024 as against net loss of Rs 3.49 crore during the previous quarter ended March 2023. Sales declined 31.32% to Rs 20.55 crore in the quarter ended March 2024 as against Rs 29.92 crore during the previous quarter ended March 2023.
For the full year,net loss reported to Rs 12.34 crore in the year ended March 2024 as against net profit of Rs 190.94 crore during the previous year ended March 2023. Sales declined 7.13% to Rs 95.20 crore in the year ended March 2024 as against Rs 102.51 crore during the previous year ended March 2023.
Tags
StockBeginner GuideAngel InvestingSME IPOEconomy MarketAIFInvestmentsMore
Stay Connected, Stay Informed –
Join Our
Don’t miss out on exclusive updates, market trends, and real-time investment opportunities. Be the first to know about the latest unlisted stocks, IPO announcements, and curated Fact Sheets, delivered straight to your WhatsApp.
Pre Ipo
Upcoming IPO
Unicorn